
Erlamide 60mg Tablet
Marketer
Sun Pharma Laboratories Ltd
Salt Composition
Apalutamide (60mg)
Overview Erlamide 60mg Tablet
Prostalon 60mg tablets are indicated for prostate cancer management. This medication inhibits testosterone's action on prostate cancer cells, thus curbing tumor growth and metastasis. It's frequently integrated into comprehensive prostate cancer treatment regimens. Prostalon 60mg tablets can be administered with or without food, always adhering to the physician's prescribed dosage and duration. Consistent medication use, as directed, is crucial; premature discontinuation or missed doses may compromise treatment efficacy and overall results. Common adverse effects include tiredness, skin eruptions, elevated blood pressure, hot flashes, joint pain, loose stools, falls, and weight reduction. These typically subside within days of commencing treatment. Persistent or worsening side effects should be reported immediately. Regular monitoring by your healthcare provider assesses treatment effectiveness. Prostalon 60mg tablets are not universally suitable. Patients with known allergies to any component or pre-existing conditions should inform their doctor before starting this medication. All current, recent, and planned medications must also be disclosed. Use is contraindicated during pregnancy and lactation due to potential harm to the fetus or infant.
Primary Ingredients of Erlamide 60mg Tablet
No information provided. Unable to rephrase.
Uses of Erlamide 60mg Tablet
Managing Cancers | Prostate Cancer Therapy
Major Benefits of Erlamide 60mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the 60mg Erlamide tablet whole; avoid chewing, crushing, or fracturing it. This medication can be taken with or without food, though consistent timing is recommended for optimal results.
Common Side effects of Erlamide 60mg Tablet:
- Fatigue
- Skin rash
- High blood pressure
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Joint pain
- Diarrhea
- Fall
- Weight loss
How to use Erlamide 60mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Erlamide 60mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Erlamide 60mg Tablet works:
Androgen receptors fuel the growth and survival of prostate cancer cells. This dependence persists even when cancer develops resistance to typical hormone treatments (castration-resistant prostate cancer), as these receptors remain active and stimulate tumor development. Erlamide 60mg Tablets counteract this by directly inhibiting androgen receptor activation, thereby preventing androgen binding and disrupting the signaling cascade responsible for prostate cancer cell proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Erlamide 60mg Tablets may pose safety risks; seek medical advice before combining them.
PregnancyUNSAFE
Use of Erlamide 60mg tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician, as research in both animal and human subjects indicates substantial risks to fetal development.
Breast feedingUNSAFE
Lactation and the use of Erlamide 60mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingSAFE
Driving ability is typically unaffected by Erlamide 60mg Tablets.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Erlamide 60mg tablets without requiring a change in dosage.
LiverSAFE IF PRESCRIBED
Patients with hepatic impairment can safely use Erlamide 60mg tablets without requiring a dosage alteration.
What if you forget to take Erlamide 60mg Tablet :
Should you forget a dose of Erlamide 60mg Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Erlamide 60mg Tablet
| Label | Value |
|---|---|
| Chemical Category | N-Phenylimidazolidines |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
